Volume : 10, Issue : 05, May – 2023

Title:

26.SODIUM ALGINATE AS A CARRIER FOR ORAL GASTRORETENTIVE IN- SITU GELLING SYSTEM: AN INSIGHT REVIEW
‬

Authors :

Vanshika K. Sahu*, Vikrant P. Wankhade, Dattahari N. Dhage, Ninad Burkhande, Sanket Rankhamb

 

Abstract :

Abstract:
Over the past ten years, in-situ gelling drug delivery devices have attracted a lot of attention. They are in a sol state prior to delivery, and they get converted to gel when exposed to a wide range of physical stimuli, including changes in temperature, pH, and the presence of ions. One of the natural polymers employed frequently in protein and drug delivery systems is alginate. Oral administration of liquid dosage forms with in situ gelling properties may be beneficial for elderly patients who have difficulty swallowing. Numerous uses for sodium alginate have prompted researchers to concentrate on developing novel in-situ gelling systems. Oral sustained release drug delivery has several advantages over other dosage forms, such as simpler dose administration, increased patient compliance, formulation flexibility, and cost effectiveness, and is therefore receiving more and more attention in the pharmaceutical industry. The chemistry of sodium alginate, the rationale for using alginate as a carrier for oral in-situ gelling systems, the principle of in situ gel formation, the method for preparation of oral Gastroretentive in-situ gel, and a literature survey on alginate-based oral in-situ therapy for various therapeutic agents have been discussed in this paper. This article provides a comprehensive review of alginate’s current status and advancement in the sol-to-gel transition phase. The future of alginate polymer applications in pharmaceutical and biomedical research is bright. Alginate’s safety, biocompatibility, and ease of preparation are some of its most significant features. The demand for the development of liquid oral controlled-release drug delivery systems increased due to the expected improvement in patient compliance and flexibility of dosing. Overcoming the potential for dose dumping was necessary for the area’s advancement. This prompted researchers to use a variety of gastro-retentive techniques to prevent dose dumping once the rigid gel structure in the intestinal environment was destroyed. As a result, researchers must update the developments in alginate-based drug delivery systems, and this review provides advice for future study.
Key words: In-situ gelling systems, Drug Delivery, Sodium Alginate, pH induced ion gelation, sol to gel transition.

Cite This Article:

Please cite this article in press Vanshika K. Sahu et al, Sodium Alginate As A Carrier For Oral Gastroretentive In- Situ Gelling System: An Insight Review., Indo Am. J. P. Sci, 2023; 10 (05).

Number of Downloads : 10

References:

1. Shimoyama, Tetsuya, Kunihiko Itoh, Michiya Kobayashi, Shozo Miyazaki, Antony D’Emanuele, and David Attwood. (2012) Oral liquid In-situ gelling methylcellulose/ alginate formulations for sustained drug delivery to dysphagic patients. Drug Dev Ind Pharm. 2012; 38(8):952-60.
2. Nagarwal, Ramesh C., and J. K. Pandit. (2008) Phase transition system: novel oral in-situ gel Curr Drug Deliv. 2008; 5(4):282-9.
3. Rajmane, Archana, Rahul Trivedi, and Tanaji Nandgude. A Novel approach to Enhance Gastric Retention for better Therapeutic Activity: Gastro Retentive Drug Delivery System. Res J Pharm Technol. 2022; 15(7): 3324-30.
4. Vigani, Barbara, Silvia Rossi, Giuseppina Sandri, Maria Cristina Bonferoni, Carla M. Caramella, et al. Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes. Pharmaceutics. 2020; 12(9): 859.
5. Grosso, Roberto, and M-Violante de-Paz. Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations. Pharmaceutics. 2022; 14(7):1340.
6. Kim, Jong Hee, Seung Hyun Song, Sang Hoon Joo, Gyu Hwan Park, and Kwon-Yeon Weon. Formulation of a Gastroretentive In-Situ Oral Gel Containing Metformin HCl Based on DoE. Pharmaceutics. 2022; 14(9): 1777.
7. Naseem F, Shah SU, Rashid SA, Farid A, Almehmadi M, Alghamdi S. Metronidazole Based Floating Bioadhesive Drug Delivery System for Potential Eradication of H. pylori: Preparation and In Vitro Characterization. Polymers. 2022; 14(3): 519.
8. Rajora A, Nagpal K. A critical review on floating tablets as a tool for achieving better gastric retention. Crit Rev Ther Drug Carr. 2022; 39(1): 65-103.
9. Tønnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm. 2002; 28(6):621-30.
10. Jain D, Bar-Shalom D. Alginate drug delivery systems: application in context of pharmaceutical and biomedical research. Drug Dev Ind Pharm. 2014; 40(12):1576-84.
11. Draget, K. I., et al (1997) Alginate based new materials. Int J Biol Macromol. 1997; 21(1-2):47-55.
12. Essa EA, Elebyary TT, Abdelquader MM, El Maghraby GM, Elkordy AA. Smart liquids for oral controlled drug release: An overview of alginate and non-alginate-based systems. J Drug Deliv Sci Technol. 2021; 1; 61:102211.
13. Srinivas LA, Sagar SH. Design, optimization, and evaluation of raft forming gastro retentive drug delivery system of lafutidine using box-behnken design. Int J Appl Pharm. 2022; 14 (1): 266-274.
14. Rahi FA. Review Article on Advanced Polymers Used in Gastroretentive Drug Delivery Systems (GDDS). Maaen Journal for Medical Sciences. 2021; 1(1):1.
15. Kim, H. M. Raft formation of sodium alginate in the stomach. J Neurogastroenterol Motil. 2016; 22(4): 705-706.
16. Paxman, J.R., Richardson, J.C., Dettmar, P.W. and Corfe, B.M. Daily ingestion of alginate reduces energy intake in free-living subjects. Appetite. 2008; 51(3): 713-719.
17. Harden, C.J., Richardson, J.C., Dettmar, P.W., Corfe, B.M. and Paxman, J.R. An ionic-gelling alginate drink attenuates postprandial glycaemia in males. J Func Foods. 2012; 4(1): 122-128.
18. Sachan, N.K., Pushkar, S., Jha, A. and Bhattcharya, A. Sodium alginate: the wonder polymer for controlled drug delivery. J Pharm Res. 2009; (8):1191-9.
19. Pathan VT, Gulecha VS, Zalte AG, Bendale AJ. In-Situ Gel System – A Novel Approach for Controlled Release. J Glob Trends Pharm Sci. 2020; 11 (4): 8564 – 8574.
20. Madan, J.R., Adokar, B.R. and Dua, K. Development and evaluation of In-situ gel of Pregabalin. Int J Pharm Investig. 2015; 5(4): 226.
21. Sudhi, U.S., Kumar, S.S., Nowfiya, F.N., Mathan, S. and Dharan, S.S. Floating Oral In-Situ Gelling System: A Review. J. Pharm. Sci. Res. 2020; 12(10):1315-9.
22. Basu, A., Masareddy, R.S., Patil, A. and Bolmal, U. Design and characterization of sustained release In-situ gastric floating gel of ropinirole hydrochloride. Indian J Pharm Educ Res. 2021; 55 (2): 374-382.
23. Patel, T., Desai, S., Jain, H., Meshram, D. and Rahevar, K. Formulation and Evaluation of Floating In-Situ Gel of Nicardipine Hydrochloride. J drug deliv ther. 2022; 12(3-S):196-211.
24. Himawan, A., Djide, N.J.N., Mardikasari, S.A., Utami, R.N., Arjuna, A., Donnelly, R.F. et al. A novel in vitro approach to investigate the effect of food intake on release profile of valsartan in solid dispersion-floating gel in-situ delivery system. Eur J Pharm Sci. 2022; 168: 106057.
25. Siripruekpong, Worrawee & Kerdsakundee, Nattha & Parinyakub, Thanapon & Wiwattanapatapee, Ruedeekorn. Development and Evaluation of floating In-situ gel for oral delivery of propranolol HCl. Thai J. Pharm. Sci. 2017; 41(5): 65.
26. Asmaa EH, Afaf RA, Asmaa EM. Development and Characterization of In-Situ Gel Containing Leflunomide as a Gastro-retentive Drug Delivery. Int J Pharm Sci Rev Res. 2020; 64 (2): 8-16.
27. Padmasri B., Nagaraju R. Formulation and Evaluation of Novel In-situ Gel System in The Management of Rheumatoid Arthritis. Int J App Pharm. 14 (5): 62-68.
28. Mahmoud, D.B., Shukr, M.H. and ElMeshad, A.N. Gastroretentive cosolvent-based In-situ gel as a promising approach for simultaneous extended delivery and enhanced bioavailability of Mitiglinide calcium. J Pharm Sci. 2019; 108(2): 897-906.
29. Mathews, R., Rao, B.P., Abbulu Konde, S.S., Nawres, A. And Suresh, C. Statistical design and development of a liquid oral floating In-situ gel of metformin hydrochloride for sustained release: Pharmacodynamic and toxicity (histopathology) studies. Int J App Pharm. 2019; 11(5): 96-104.
30. Sharma, A., Sharma, J., Kaur, R. and Saini, V. Development and characterization of In-situ oral gel of Spiramycin. Biomed Res. Int. 2014; (2014): 1-7.
31. Hani, U., Rahamathulla, M., Osmani, R.A.M., Begum, M.Y., Wahab, S., Ghazwani, M., et al. Development and Characterization of Oral Raft Forming In Situ Gelling System of Neratinib Anticancer Drug Using 32 Factorial Design. Polymers. 2022; 14(13): 2520.
32. Abdul Rasool, B.K., Khalifa, A., Abu-Gharbieh, E. and Khan, R. Employment of alginate floating in situ gel for controlled delivery of celecoxib: Solubilization and formulation studies. Biomed Res. Int. 2020; (2020): 1-10.
33. Mercy, M., & Banwait, H. Formulation and Evaluation of Gastroretentive Floating In-Situ Gel of Minocycline HCL. Pharma Science Monitor. 2018; 9(2): 99-111.
34. Pandya, K., Aggarwal, P., Dashora, A., Sahu, D., Garg, R., Pareta, L.K., et al. Formulation and evaluation of oral floatable in-situ gel of Ranitidine hydrochloride. J drug deliv Ther. 2013; 3(3): 90-97.
35. Bobade, N. N., & Pande, S. D. Formulation and evaluation of controlled release gastro-retentive In-situ gel for diltiazem hydrochloride. Indian J Pharm Educ Res. 2016; 50(3): S254-65.
36. Ahmed, M.G., Kapoor, C. and Adinarayana, S. Formulation and evaluation of oral sustained in situ gelling system of roxatidine. Indonesian J Pharm. 2017; 28(3):178.
37. Madan, M., Bajaj, A., Lewis, S., Udupa, N. and Baig, J.A. In-situ forming polymeric drug delivery systems. Indian J Pharm Sci. 2009; 71(3): 242.
38. Modasiya, M.K., Prajapati, B.G., Patel, V.M. and Patel, J.K. Sodium alginate based In-situ gelling system of famotidine: preparation and in-vivo characterizations. e-Journal of Science and Technology. 2010; 5(1): 27-42.